首頁 > 市場調查報告書 > 醫療設備

體外診斷

瘧疾診斷市場規模、佔有率和成長分析（按產品、技術、應用和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902503

瘧疾診斷市場規模、佔有率和成長分析（按產品、技術、應用和地區分類）－2026-2033年產業預測

Malaria Diagnostics Market Size, Share, and Growth Analysis, By Product (Instruments, Kits & reagents), By Technology (Microscopy, Rapid diagnostic tests), By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球瘧疾診斷市場規模將達到 8.842 億美元，到 2025 年將達到 9.2576 億美元，到 2033 年將達到 13.3682 億美元，在預測期（2026-2033 年）內複合年成長率為 4.7%。

由於調查方法的技術進步，特別是分子診斷和快速診斷測試（RDT）領域的技術進步，全球瘧疾診斷市場正經歷顯著擴張。這些創新提高了靈敏度、特異性和易用性，使得就地檢驗（POCT）越來越受歡迎，尤其是在資源匱乏的地區。人們對早期瘧疾檢測重要性的認知不斷提高、政府的支持性政策以及全球衛生組織的資金投入，都進一步推動了市場成長。然而，偏遠地區醫療基礎設施的匱乏、成本效益問題以及對某些診斷測試可靠性的質疑等挑戰可能會阻礙市場發展。克服這些障礙需要公共和私營部門利益相關人員的合作，共同開發可近、有效且符合當地文化的診斷解決方案，從而顯著降低瘧疾在全球的影響。

推動全球瘧疾診斷市場發展的因素

全球瘧疾診斷市場深受瘧疾高發地區的影響，尤其是撒哈拉以南非洲和亞洲部分地區。在這些地區，準確快速的診斷解決方案對於成功控制和遏制瘧疾至關重要。由於瘧疾仍然是嚴重的公共衛生挑戰，快速識別病例和製定高效治療方案的需求推動了對創新診斷工具的需求。滿足這些診斷需求對於改善健康狀況和促進有效的瘧疾控制至關重要。

全球瘧疾診斷市場限制因素

全球瘧疾診斷市場面臨研發投入不足的挑戰，可能限制創新診斷技術的出現。缺乏資金支持旨在開發更靈敏、更特異、更經濟的診斷測試的研究舉措，阻礙了這一重要領域的發展。如果沒有足夠的資金支持，改善診斷工具的研發過程可能會受阻，從而影響瘧疾檢測和控制策略的整體有效性。因此，缺乏創新可能導致瘧疾控制面臨持續的挑戰，並限制醫療衛生系統有效應對瘧疾的能力。

全球瘧疾診斷市場趨勢

全球瘧疾診斷市場正經歷著向亞洲、拉丁美洲和非洲等新興市場的重大轉移。這一趨勢主要受醫療保健投資增加和公眾對感染疾病認知的提高所推動。這些地區的政府已實施強而有力的瘧疾防治政策，為市場成長創造了有利條件。各公司正抓住這項機遇，開發經濟高效且符合當地文化的診斷解決方案，以滿足當地居民的特定需求。這種策略重點不僅提高了診斷服務的可近性，還促進了與當地醫療機構的夥伴關係，為公司有效進入並立足這些快速成長的市場奠定了基礎。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Abbott Laboratories（United States）
Bio-Rad Laboratories, Inc.（United States）
Siemens Healthineers AG（Germany）
Thermo Fisher Scientific Inc.（United States）
F. Hoffmann-La Roche Ltd（Switzerland）
bioMerieux SA（France）
Beckman Coulter, Inc.（United States）
Cepheid Inc.（United States）
Danaher Corporation（United States）
Hologic, Inc.（United States）
Illumina, Inc.（United States）
Qiagen NV（Netherlands）
Sysmex Corporation（Japan）
Nikon Corporation（Japan）
Olympus Corporation（Japan）
DiaSorin SpA（Italy）
Trinity Biotech plc（Ireland）
FujiFilm Corporation（Japan）

結論與建議

簡介目錄

Product Code: SQMIG35B2208

Global Malaria Diagnostics Market size was valued at USD 884.2 Million in 2024 and is poised to grow from USD 925.76 Million in 2025 to USD 1336.82 Million by 2033, growing at a CAGR of 4.7% during the forecast period (2026-2033).

The global malaria diagnostics market is experiencing remarkable expansion driven by technological advancements in diagnostic methodologies, particularly in molecular diagnostics and rapid diagnostic tests (RDTs). These innovations enhance sensitivity and specificity and facilitate easier usage, making point-of-care testing increasingly popular, especially in resource-limited settings. The growing awareness of early malaria detection and supportive governmental initiatives, alongside funding from organizations dedicated to global health, further bolster market growth. However, challenges such as inadequate healthcare infrastructure in remote areas, affordability issues, and questions regarding the reliability of some diagnostic tests may impede progress. Overcoming these barriers necessitates collaborative efforts among public and private sector stakeholders to create accessible, effective, and culturally appropriate diagnostic solutions that can substantially mitigate malaria's impact worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Malaria Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Malaria Diagnostics Market Segments Analysis

Global Malaria Diagnostics Market is segmented by Product, Technology, End-use and region. Based on Product, the market is segmented into Instruments and Kits & reagents. Based on Technology, the market is segmented into Microscopy, Rapid diagnostic tests, Molecular diagnostic tests and Other technologies. Based on End-use, the market is segmented into Clinics, Hospitals, Diagnostic centers and Other end-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Malaria Diagnostics Market

The Global Malaria Diagnostics market is significantly influenced by regions facing a substantial malaria burden, especially in sub-Saharan Africa and certain areas of Asia. In these locations, the imperative for precise and prompt diagnostic solutions becomes paramount for the successful management and containment of the disease. As malaria continues to pose a serious public health challenge, the demand for innovative diagnostic tools rises, driven by the necessity for rapid identification of cases and efficient treatment decisions. Addressing these diagnostic needs is essential for improving health outcomes and advancing efforts to combat malaria effectively.

Restraints in the Global Malaria Diagnostics Market

The Global Malaria Diagnostics market faces challenges due to inadequate investment in research and development, which may restrict the emergence of innovative diagnostic technologies. This scarcity of funding for research initiatives aimed at creating more sensitive, specific, and cost-effective diagnostic tests impedes advancement in this vital area. Without sufficient financial support, progress in developing improved diagnostic tools is hindered, potentially affecting the overall effectiveness of malaria detection and management strategies. Consequently, the lack of innovation can lead to persistent challenges in addressing malaria effectively, limiting the ability of healthcare systems to combat the disease efficiently.

Market Trends of the Global Malaria Diagnostics Market

The Global Malaria Diagnostics market is witnessing a significant shift towards emerging markets across Asia, Latin America, and Africa, driven by escalating healthcare investments and heightened public awareness of infectious diseases. Governments in these regions are implementing robust initiatives to combat malaria, creating a fertile landscape for growth. Companies are seizing this opportunity by developing cost-effective and culturally attuned diagnostic solutions that meet the specific needs of local populations. This strategic focus not only enhances accessibility to diagnostics but also fosters partnerships with local healthcare providers, thereby positioning businesses to effectively penetrate and establish a foothold in these burgeoning markets.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Malaria Diagnostics Market Size by Product & CAGR (2026-2033)

Market Overview
Instruments
Kits & reagents

Global Malaria Diagnostics Market Size by Technology & CAGR (2026-2033)

Market Overview
Microscopy
Rapid diagnostic tests
Molecular diagnostic tests
- Conventional PCR
- Real-time PCR
Other technologies

Global Malaria Diagnostics Market Size by End-use & CAGR (2026-2033)

Market Overview
Clinics
Hospitals
Diagnostic centers
Other end-users

Global Malaria Diagnostics Market Size & CAGR (2026-2033)

North America (Product, Technology, End-use)
- US
- Canada
Europe (Product, Technology, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technology, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technology, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technology, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cepheid Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nikon Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FujiFilm Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments